DEVELOPMENT OF A TECHNIQUE FOR THE MASS-SPECTROMETRIC DETERMINATION OF GONADOTROPIN-RELEASING HORMONE AND ITS ANALOGS FOR DOPING CONTROL

In the present study, a rapid, sensitive, and selective method for determination of several synthetic analogues of gonadotropin-releasing hormone in human urine by solid-phase extraction and ultraperformance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) was developed. Various parameters affecting sample preparation, LC separation, and MS/MS detection were investigated, and optimized conditions were identified. The UPLC-MS/MS system was equipped with an electrospray ion source operating in positive ion mode with selected reaction monitoring. Leuprolide-13С6 was used as internal standard for analytes quantitative assessment. The proposed method was validated considering the parameters specificity, linearity (0.1-10 ng/ml), recovery (52-98%), limit of detection (0.1 ng/ml), matrix effects and stability.

gonadotropin-releasing hormone, gonadotropin-releasing hormone agonists, solidphase egonadotropin-releasing hormon, gonadotropin-releasing hormon agonists, solid-phase extraction, ultra-performance liquid chromatography coupled to tandem mass spectrometry, UPLCMS/MS, ultra-performance liquid chromatography coupled to high resolution mass spectrometry, UPLC-HRMS, doping control

1. Mareck U., Geyer H., Opfermann G., Thevis M., Schänzer W. Factors influencing the steroid profile in doping control analysis // J. Mass Spectrom. 2008. V. 43. № 7. P. 877–891.

2. Handelsman D.J. The rationale for banning human chorionic gonadotropin and estrogen blockers in sport // J. Clin. Endocrinol. Metab. 2006. V. 91. № 5. P. 1646–1653.

3. Stenman U.H., Hotakainen K., Alfthan H. Gonadotropins in doping: pharmacological basis and detection of illicit use // Br. J. Pharmacol. 2008. V. 154. № 3. P. 569–583.

4. Gore A.C. Gonadotropin-releasing hormone (GnRH) neurons: gene expression and neuroanatomical studies // Prog. Brain Res. 2002. V. 141. P. 193–208.

5. Esposito S., Deventer K., Geldof L., Van Eenoo P. In vitro models for metabolic studies of small peptide hormones in sport drug testing // J. Pept. Sci. 2015. V. 21. № 1. P. 1–9.

6. Richards S.L., Cawley A.T., Cavicchioli R., Suann C.J., Pickford R., Raftery M.J. Aptamer based peptide enrichment for quantitative analysis of gonadotropin-releasing hormone by LC–MS/MS // Talanta. 2016. V. 150. P. 671–680.

7. Thomas A., Walpurgis K., Krug O., Schänzer W., Thevis M. Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry // J. Chromatogr. A 2012. V. 1259. P. 251–257.

8. Thomas A., Geyer H., Kamber M., Schänzer W., Thevis M. Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS // J. Mass Spectrom. 2008. V. 43. № 7. P. 908–915.

9. Handelsman D.J., Swerdloff R.S. Pharmacokinetics of gonadotropin-releasing hormone and its analogs // Endocr. Rev. 1986. V. 7. № 1. P. 95–105.

10. Yoshida T. Peptide separation by HydrophilicInteraction Chromatography: a review // J. Biochem. Biophys. Methods. 2004. V. 60. № 3. P. 265–280.

11. Sample preparation and chromatografic columns of company Waters // Analiticheskiy kontrol'. Farmatcevticheskaya otrasl' (Analytical Control. Pharmaceutical Industry). 2010. V. 23. № 6. P. 88-89 (in Russ.).

12. Garcia M.C. The effect of the mobile phase additives on sensitivity in the analysis of peptides and proteins by high-performance liquid chromatographyelectrospray mass spectrometry // J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2005. V. 825. № 2. P. 111–123.

13. Roepstorff P., Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides // Biomed. Mass Spectrom. 1984. V. 11. № 11. P. 601.

14. Johnson R.S., Martin S.A., Biemann K., Stults J.T., Throck Watson J. Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine // Anal. Chem. 1987. V. 59. № 21. P. 2621–2625.

15. Bakhtiar R., Guan Z. Electron capture dissociation mass spectrometry in characterization of peptides and proteins // Biotechnol. Lett. 2006. V. 28. № 14. P. 1047–1059.

16. Sofianos Z.D., Katsila T., Kostomitsopoulos N., Balafas V., Matsoukas J., Tselios T., Tamvakopoulos C. In vivo evaluation and in vitro metabolism of leuprolide in mice – mass spectrometry-based biomarker measurement for efficacy and toxicity // J. Mass Spectrom. 2008. V. 43. № 10. P. 1381–1392.

17. Michalet S., Favreau P., Stocklin R. Profiling and in vivo quantification of proteins by high resolution mass spectrometry: the example of goserelin, an analogue of luteinizing hormone-releasing hormone // Clin. Chem. Lab. Med. 2003. V. 41. № 12. P. 1589–1598.

18. Kim H.K. Lee T.H., Suh J.H., Eom H.Y., Min J.W., Yeom H., Kim U., Jung H.J., Cha K.H., Choi Y.S., Youm J.R., Han S.B. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma // J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2010. V. 878. № 24. P. 2235–2242.

19. Bioanalysis of biotherapeutics summary [electronic resource] // Waters : [site] : ― URL: http://www.waters.com/webassets/cms/library/docs/local_seminar_presentations/DA_Waters_Biotherapeutic_Bioanalysis_summary.pdf. Date of access: 15.08.2016.